← Back to All Filings

Repligen COO Sells $331k in RGEN Stock

Low SignificanceNovember 19, 2025 at 4:32:23 PM EST

REPLIGEN CORP

$RGEN4CIK: 0000730272

Subscribe to track RGEN

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Repligen COO Sells $331k in RGEN Stock

Company: REPLIGEN CORP (RGEN) Form: 4 | Filed: 2025-11-19 Significance: Low

Insider: Bylund James Title: Chief Operating Officer | Relationship: Officer

Transaction: • Type: Sale • Shares: 2,191 • Price: $151.21 • Value: $331,259 • Owned After: 21,520

Key Insight: The transaction is of low significance, representing less than 0.01% of the company's market cap and shares outstanding. The sale constitutes approximately 9.2% of the insider's direct holdings.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: REPLIGEN CORP (RGEN)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Operating Officer, James Bylund, sold 2,191 shares of common stock for a total value of approximately $331,259.
  • Market Impact: This transaction is considered routine and is unlikely to have a material impact on the stock price due to its small size relative to the company's market capitalization.

Company Information

FieldValue
CompanyREPLIGEN CORP
Ticker SymbolRGEN
CIK0000730272
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameBylund James
CIK0001849642
Title/PositionChief Operating Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-18
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved2,191
Price Per Share$151.21 (Weighted Average)
Total Value$331,259.11
Shares Owned After21,520
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$331,259.11
% of Market Cap0.0039%
Shares Transacted2,191
% of Shares Outstanding0.0039%
Post-Transaction Ownership21,520 shares (0.038% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Repligen has a market capitalization of $8.58 billion. This $331k sale is negligible in comparison, representing a tiny fraction of the company's total value.
  • Ownership Concentration: The COO's post-transaction holding of 21,520 shares represents a very small portion (0.038%) of the total shares outstanding, indicating low ownership concentration from this insider.
  • Transaction Significance: The sale represents approximately 9.2% of the insider's direct holdings. While not a trivial amount for the individual, it is immaterial from a market perspective, falling well below the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction size is too small relative to the company's market cap and daily trading volume to influence investor sentiment or stock price.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction is unlikely to cause any noticeable change in trading volume.
  • Sentiment Indicator: Neutral. This is a routine insider sale, likely for personal financial planning, and does not signal a change in the company's outlook.

Additional Context

Transaction Notes

  • Special Circumstances: The sale price of $151.21 is a weighted average, with shares sold in multiple transactions ranging from $151.21 to $151.62. This is a common practice for executing orders to minimize market impact.
Topics:#SECFiling#InsiderTrading#RGEN#Repligen#Form4#InsiderSell#StockMarket#MarketAnalysis#Finance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.